Showing results (291-300 of 406) with videos related to

Sort By:
Pageof 41
Neuroimmunomodulation|January 7, 1999
Use of neuroendocrine hormones to promote reconstitution after bone marrow transplantationM A Woody, L A Welniak, S Richards, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1989
Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrowR H Wiltrout, A M Pilaro, M E Gruys, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|March 1, 1996
Use of the polymerase chain reaction technique to determine c-myc expression in follicular center cell lymphomaJ Wang, L J Medeiros, D L Longo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Induction of interleukin 1 receptor antagonist after interleukin 1 therapy in patients with cancerW C Kopp, W J Urba, H C Rager, et al.
The Journal of Biological Chemistry|September 8, 1995
Polo-like kinase is a cell cycle-regulated kinase activated during mitosisR Hamanaka, M R Smith, P M O'Connor, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1992
Enhanced lymphokine production and lymphokine receptor expression in multiple antibody-stimulated human CD4+ peripheral blood lymphocytesK C Conlon, A C Ochoa, W C Kopp, et al.
Journal of the National Cancer Institute|October 5, 1988
Deletion of 3(p14p23) in secondary erythroleukemia arising in long-term survivors of small cell lung cancerJ Whang-Peng, E C Lee, J D Minna, et al.
Cell|August 1, 1982
The fine specificity of antigen and Ia determinant recognition by T cell hybridoma clones specific for pigeon cytochrome cS M Hedrick, L A Matis, T T Hecht, et al.
Lancet (London, England)|April 22, 1995
Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donorL W Kwak, D D Taub, P L Duffey, et al.
Journal of the National Cancer Institute|January 18, 1995
Enhancement by recombinant human interferon alfa of the reversal of multidrug resistance by MRK-16 monoclonal antibodyW E Fogler, J W Pearson, K Volker, et al.
Pageof 41